Head and Neck Cancer
Showing NaN - NaN of 92
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)
Recruiting
- HER2-positive
- +30 more
- CT-0508
-
Duarte, California
- +4 more
Feb 1, 2022
Head Neck Cancer Trial in United States (ADP-A2M4 in combination with pembrolizumab.)
Withdrawn
- Head and Neck Cancer
- ADP-A2M4 in combination with pembrolizumab.
-
Phoenix, Arizona
- +7 more
Nov 8, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
-
Irvine, California
- +10 more
Nov 4, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Evorpacept
- +2 more
-
Irvine, California
- +10 more
Nov 4, 2021
Head Neck Cancer Trial in Worldwide (cetuximab, intensity-modulated radiation therapy)
Active, not recruiting
- Head and Neck Cancer
- cetuximab
- intensity-modulated radiation therapy
-
Birmingham, Alabama
- +263 more
Aug 2, 2021
Head Neck Cancer Trial in Worldwide (ASP-1929 Photoimmunotherapy, Physician's Choice SOC)
Recruiting
- Head and Neck Cancer
- ASP-1929 Photoimmunotherapy
- Physician's Choice SOC
-
Miami, Florida
- +36 more
Mar 26, 2021
Urothelial Carcinoma, Head Neck Cancer, Melanoma Trial in Canada, Spain, United States (Autologous genetically modified MAGE
Completed
- Urothelial Carcinoma
- +3 more
- Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells
-
Boston, Massachusetts
- +10 more
Dec 17, 2020
Head Neck Cancer Trial in Chapel Hill, Nashville, Seattle (Cetuximab, Nab-paclitaxel, Carboplatin)
Anemia, Head Neck Cancer Trial in Canada, Korea, Republic of, United States (biological, drug, radiation)
Completed
- Anemia
- Head and Neck Cancer
- epoetin alfa
- +2 more
-
Birmingham, Alabama
- +260 more
Oct 21, 2020
Head Neck Cancer Trial in Canada, United States (cisplatin, radiation therapy)
Completed
- Head and Neck Cancer
- cisplatin
- radiation therapy
-
Birmingham, Alabama
- +257 more
Oct 21, 2020
Head Neck Cancer, Skin Reactions Secondary to Radiation Therapy Trial in Canada, United States (drug, procedure, radiation)
Completed
- Head and Neck Cancer
- Skin Reactions Secondary to Radiation Therapy
- Biafine cream
- +2 more
-
Birmingham, Alabama
- +259 more
Oct 21, 2020
Head Neck Cancer Trial in Nashville (Yoga Video, Posture and Strengthening Video, Relaxation Video)
Terminated
- Head and Neck Cancer
- Yoga Video
- +6 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Oct 6, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Head and Neck Tumors, Head Neck Cancer, Head and Neck Lymphedema Trial in Springfield, Nashville (Flexitouch head and neck
Completed
- Head and Neck Neoplasms
- +2 more
- Flexitouch head and neck lymphedema treatment system
- Standard home lymphedema care
-
Springfield, Illinois
- +1 more
Jul 21, 2020
Head Neck Cancer Trial in United States (Everolimus (RAD 001), Placebo)
Terminated
- Head and Neck Cancer
- Everolimus (RAD 001)
- Placebo
-
Miami, Florida
- +16 more
Mar 25, 2020
Head Neck Cancer Trial in Worldwide (biological, dietary supplement, drug, procedure)
Completed
- Head and Neck Cancer
- recombinant interferon alfa
- +3 more
-
Birmingham, Alabama
- +88 more
Dec 30, 2018
Head Neck Cancer Trial in United States (IMC-A12 (cixutumumab), cetuximab (Erbitux ®))
Completed
- Head and Neck Cancer
- IMC-A12 (cixutumumab)
- cetuximab (Erbitux ®)
-
Orange, California
- +13 more
Mar 17, 2018
Head Neck Cancer, Lymphedema Trial in Nashville (Home-based Lymphedema Care Program)
Terminated
- Head and Neck Cancer
- Lymphedema
- Home-based Lymphedema Care Program
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jan 23, 2018
Dysphagia, Head Neck Cancer, Mucositis Trial in Nashville (behavioral, drug, procedure)
Terminated
- Dysphagia
- +3 more
- exercise intervention
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
May 28, 2017
Secondary Lymphedema on Symptoms, Functional Status, and Quality
Completed
- Cancer Survivor
- +2 more
-
Nashville, Tennessee
- +1 more
Apr 6, 2017
DevelopingChecklist of Lymphedema Symptoms in Head and Neck
Completed
- Head and Neck Cancer
- Lymphedema
-
Nashville, Tennessee
- +2 more
Apr 6, 2017